BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34669096)

  • 1. Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.
    Bonelli L; Valle I; Rebora I; Ricci P; Biocchi L; Bruschi G; Parodi S; Bruzzone C; Varesco L
    Fam Cancer; 2022 Jul; 21(3):309-318. PubMed ID: 34669096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
    Hessock M; Brewer T; Hutson S; Anderson J
    Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
    Appel SJ; Cleiment RJ
    J Natl Black Nurses Assoc; 2015 Dec; 26(2):17-26. PubMed ID: 27045154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines.
    Julian-Reynier C; Eisinger F; Moatti JP; Sobol H
    Eur J Hum Genet; 2000 Mar; 8(3):204-8. PubMed ID: 10780786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
    Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
    Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer.
    Pruthi S; Gostout BS; Lindor NM
    Mayo Clin Proc; 2010 Dec; 85(12):1111-20. PubMed ID: 21123638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is family history related to preventive health behaviors and medical management in breast cancer patients?
    Madlensky L; Flatt SW; Bardwell WA; Rock CL; Pierce JP;
    Breast Cancer Res Treat; 2005 Mar; 90(1):47-54. PubMed ID: 15770526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany.
    Vetter L; Keller M; Bruckner T; Golatta M; Eismann S; Evers C; Dikow N; Sohn C; Heil J; Schott S
    Breast Cancer Res Treat; 2016 Apr; 156(2):289-99. PubMed ID: 26960712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006-2016.
    Adolph L; Warias A; Stairs J; Collins-McNeil K; Penney L; Kieser K
    BMC Womens Health; 2022 Jun; 22(1):263. PubMed ID: 35768821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Are you at risk for hereditary breast cancer?": development of a personal risk assessment tool for hereditary breast and ovarian cancer.
    Cohn WF; Jones SM; Miesfeldt S
    J Genet Couns; 2008 Feb; 17(1):64-78. PubMed ID: 18181014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
    MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
    Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening results of individuals with high risk BRCA-related breast/ovarian cancer in Trakya region of Turkey.
    Demir S; Tozkir H; Gurkan H; Atli EI; Yalcintepe S; Atli E; Sezer YA; Eker D; Tuncbilek N; Tastekin E; Ozen Y; Cicin I
    J BUON; 2020; 25(3):1337-1347. PubMed ID: 32862574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest.
    Moura JB; Ghedin CC; Takakura ÉT; Scandolara TB; Rech D; Panis C
    Rev Bras Ginecol Obstet; 2021 Aug; 43(8):616-621. PubMed ID: 34547796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Awareness and concern about ovarian cancer among women at risk because of a family history of breast or ovarian cancer.
    Andersen MR; Bowen D; Yasui Y; McTiernan A
    Am J Obstet Gynecol; 2003 Oct; 189(4 Suppl):S42-7. PubMed ID: 14586320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
    Bellcross CA
    Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of women at high risk of hereditary breast cancer in the Veneto Regional Program for Prevention.
    Del Sole A; Cinquetti S; Fedato C; Montagna M; Russo F; Sbrogiò LG; Zorzi M
    Epidemiol Prev; 2015; 39(4 Suppl 1):99-101. PubMed ID: 26499424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer.
    Isaacs C; Peshkin BN; Schwartz M; Demarco TA; Main D; Lerman C
    Breast Cancer Res Treat; 2002 Jan; 71(2):103-12. PubMed ID: 11881908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guideline for the prevention and early detection of breast and ovarian cancer in high risk patients, particularly in women from HBOC (hereditary breast and ovarian cancer) families].
    Singer CF; Tea MK; Pristauz G; Hubalek M; Rappaport C; Riedl C; Helbich T
    Wien Klin Wochenschr; 2012 May; 124(9-10):334-9. PubMed ID: 22644217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.